When she was on Medicaid for a time, Clour said she was repeatedly denied coverage for the Omnipod system. Since then, she ...

Carrie Hicks (D-Oklahoma City) wants Medicaid coverage for the Omnipod insulin pump to help make patients' lives better in ...

Oklahoma may add Medicaid coverage for Omnipod insulin pumps, with Senator Carri Hicks advocating for access based on its ...

Insulet Corp.’s PODD groundbreaking Omnipod 5 Automated Insulin Delivery (“AID”) system (Omnipod 5) received the FDA’s approval for use by type 2 diabetes patients (ages 18 years and above).

Insulet Corporation's Omnipod 5 System received FDA clearance for type 2 diabetes in August. Insulet reported a 26% year-over-year revenue increase in Q2 2024, driven by strong demand for Omnipod 5.

Marie Thibault’s rating is based on a few key developments surrounding Insulet’s Omnipod 5 (O5) system. The U.S. Food and Drug Administration (FDA) recently granted O5 clearance for use by ...

The recent FDA clearance for the Omnipod 5 (O5) to be used by Type 2 diabetes patients has opened up a substantial new market segment, which is evidenced by the company’s optimistic outlook and ...

Insulet Corp.’s PODD recent FDA approval of Omnipod 5 for type 2 diabetes patients is set to expand the product’s market potential. The planned launch of Omnipod 5 with Abbott’s Freestyle ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its groundbreaking ...

By pairing Insulet’s Omnipod 5 pump with a continuous glucose monitor, the device will automatically adjust insulin delivery based on a person’s blood glucose levels. Insulet’s new ...

Recommended Reading Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes Insulet received Food and Drug Administration clearance on Monday for its newest insulin pump to be used by ...